SEC Form 4 · accession 0001209191-15-028609
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Officer — Executive Vice President & CFO
Period of report
Mar 23, 2015
Accepted (ET)
Mar 23, 2015 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 23, 2015 | P | 3,000 | $52.4346 | A | 173,000 | I | See Footnote |
| Common Stock | holding | — | — | — | 94,840 | D | ||
| Common StockF3 | holding | — | — | — | 10,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $52.30 to $52.56, inclusive.
- F2These shares are held by Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable Trust dated 1/27/00.
- F3These shares are held by Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA.